Search Results
Dec 11, 2025, 10:15 ET Cell Therapy Technologies Market worth $7.91 billion by 2030 | MarketsandMarkets™
Stem Cell Therapy Market - Global Forecast to 2028
More news about: MarketsandMarkets
Dec 11, 2025, 09:06 ET ZEISS celebrates 100 years of advancing innovation in the U.S.
Heart for Science" initiative inspiring the next generation of scientists by fostering enthusiasm for nature and technology. The initiative promotes STEM (science, technology, engineering and mathematics) for young people under the age of 18, with each engagement planned and organized by ZEISS employees
More news about: ZEISS Group
Dec 11, 2025, 09:00 ET Five Leading Cancer Centers Unite to Target CD123 and Eradicate Hidden Leukemia Cells
that could have broad reach across more subgroups of patients," said Garcia. "CD123 is present on the surface of AML cells and early leukemia stem cells which makes it a meaningful way to target residual disease."This multi-site study will evaluate targeting CD123 in combination with
More news about: Break Through Cancer
Dec 11, 2025, 08:20 ET St. Thomas University College of Law Welcomes ABA Council Determination of Compliance
Liberal Arts and Social Sciences. President David A. Armstrong, J.D.'s new "Pursue Excellence" strategic vision seeks to build a new 99,000-square-foot STEM and nursing building, expand the College of Law, and construct new athletic facilities. Media Contact:Belkis Mejia Perdomo
More news about: St. Thomas University
Dec 11, 2025, 07:49 ET From Farm to Future: Chefs, Food Industry Leaders, and Engineers Needed to Judge Record-Breaking STEM Competition
history.Even more notable is who is signing up. The competition is reporting a 50/50 gender split among participants, a rare milestone in STEM programming. Additionally, the 2025-26 season features the highest-ever participation from teams in the DC, Maryland, and Virginia (DMV) region,
More news about: Discover Engineering
Dec 11, 2025, 07:30 ET TuHURA Biosciences Provides Corporate Update Following Recent Financing
Marrow Transplantation at Washington University School of Medicine in St. Louis; Kevin Lin, MD, PhD Student, Developmental, Regenerative, and Stem Cell Biology Program at the Washington University in St. Louis; and Tae Kon Kim, MD, PhD, Assistant Professor of Medicine, Division of Hematology
More news about: TuHURA Biosciences, Inc.
Dec 11, 2025, 07:30 ET NexGen Hyperbaric Expands National Presence to Florida, Adds New Professional Sports Customer, and Announces Flagship Facility Launch
Concussions, traumatic brain injury (TBI), and cognitive function supportRegenerative medicine: Enhanced circulation, tissue repair, and stem cell mobilizationAnti-aging and wellness: Cellular health, vitality, and longevity protocolsPatient Access & Hours
More news about: NexGen Hyperbaric
Dec 11, 2025, 07:00 ET NewcelX Expands Intellectual Property Footprint with Publication of DOXA Patent Application in China
signalling, metabolic homeostasis, and insulin sensitivity. These connections support the potential integration of DOXA mechanisms alongside NewcelX's stem-cell–derived IsletRx program for insulin-dependent diabetes. Enhanced metabolic regulation and improved neurological function may complement regenerative
More news about: NewcelX Ltd.
Dec 10, 2025, 17:51 ET Die Fondazione Telethon gibt die FDA-Zulassung von Waskyra™ (Etuvetidigene Autotemcel) bekannt, einer Gentherapie zur Behandlung des Wiskott-Aldrich-Syndroms
Wiskott-Aldrich-Syndrom (WAS) indiziert ist, die eine Mutation im WAS-Gen aufweisen, für die eine hämatopoetische Stammzelltransplantation („Hematopoietic Stem Cell Transplantation", HSCT) geeignet ist und für die kein geeigneter HLA-kompatibler verwandter Stammzellspender verfügbar ist.Was sind die
More news about: Fondazione Telethon
Dec 10, 2025, 15:26 ET AIChE Foundation Celebrates Engineering a Decade of Impact at the 2025 Gala
students, including Student Chapter Leaders from Stevens Institute of Technology and New Jersey Institute of Technology, as well as members of the Future of STEM Scholars Initiative (FOSSI) community. Another 5% of attendees were early-career AIChE volunteer leaders from Operating Councils and Local Sections,
More news about: American Institute Of Chemical Engineers
Dec 10, 2025, 11:02 ET C1 Research Identifies CIOs' 2026 IT Investment Priorities: Balancing Innovation with Discipline in the Era of AI
workflows, and smarter interactions across every channel.Security fundamentals: Leaders reported that most breaches still stem from basic access failures, not advanced attacks, and AI-generated audio, images, and video designed to mimic real people have become enterprise threats.
More news about: C1
Dec 10, 2025, 08:37 ET Enchanted Rock Names John Carrington CEO to Lead Next Phase of Expansion
executive with decades of experience scaling high-growth companies and bringing advanced power technologies to market. He most recently served as CEO of Stem, Inc., where he led the company through its IPO and rapid commercial expansion. His career also includes senior leadership roles at Miasole, First Solar
More news about: Enchanted Rock
Dec 10, 2025, 07:17 ET Fondazione Telethon Announces FDA approval of Waskyra™ (etuvetidigene autotemcel), a Gene Therapy for the Treatment of Wiskott-Aldrich Syndrome
syndromeWaskyra consists of a single administration of autologous CD34+ hematopoietic stem and progenitor cells that have been transduced with a lentiviral vector encoding the WAS gene.Once corrected, the stem cells are reinfused into the patient, who undergoes chemotherapy beforehand to prepare
More news about: Fondazione Telethon
Dec 10, 2025, 07:12 ET Fondazione Telethon Announces FDA approval of Waskyra™ (etuvetidigene autotemcel), a Gene Therapy for the Treatment of Wiskott-Aldrich Syndrome
Waskyra consists of a single administration of autologous CD34+ hematopoietic stem and progenitor cells that have been transduced with a lentiviral vector encoding the WAS gene.Once corrected, the stem cells are reinfused into the patient, who undergoes chemotherapy beforehand to prepare
More news about: Fondazione Telethon
Dec 09, 2025, 17:31 ET Amyotrophic Lateral Sclerosis Market Outlook: Expanding Therapeutic Pipeline and Novel Drug Launches Propel Growth Throughout Forecast Period (2025-2034) | DelveInsight
and others.Brainstorm-Cell Therapeutics's NurOwn and Rapa Therapeutics's RAPA 501 are pioneering novel treatments for ALS through stem cell and T-cell therapy approaches. Transposon Therapeutics' TPN-101 and Ionis Pharmaceuticals' Ulefnersen are therapies specifically
More news about: DelveInsight Business Research, LLP
Dec 09, 2025, 14:00 ET For A Bright Future Foundation Announces 2025 STEM Scholarship Recipients
("FABF"), a 501(c)(3) nonprofit organization dedicated to supporting the needs of underserved students, has announced the 2025 recipients of its prestigious STEM Scholarship. This year's awardees include Ean Kim, Jennifer Espinosa Maldonado, Joshua Barrera, Kana Hutchens, Melanie Laveriano, and Morelia Gil Cubillo—six
More news about: Louis Hernandez Jr.'s Foundation For A Bright Future
Dec 09, 2025, 11:57 ET Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
at revolutionizing a diabetes treatment. This partnership will advance a proprietary differentiation process achieving high-efficiency conversion of stem cells into insulin-producing and regulating cells, targeting type 1 and insulin-dependent type 2 diabetes patients globally. Avant will provide
More news about: Equity Insider
Dec 09, 2025, 11:14 ET Regenerative Patch Technologies (RPT) Announces Treatment of First Two Patients in Phase IIb Clinical Trial Assessing the Safety and Efficacy of its Allogeneic Bioengineered RPE Cell Implant for the Treatment of Advanced Dry Age-Related Macular Degeneration.
Regenerative Patch Technologies LLC is a clinical-stage company developing a stem cell-based implant technology for the treatment of retinal diseases. The CPCB-RPE1 implant, RPT's lead product, is a bio-engineered implant consisting of stem cell-derived, retinal pigmented epithelial (RPE) cells on an ultrathin
More news about: Regenerative Patch Technologies
Dec 09, 2025, 10:00 ET Qualia Life Sciences, Award-Winning Supplement Brand, Celebrates Its 10th Year Anniversary
Qualia Stem Cell.*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat,
More news about: Qualia Life Sciences
Dec 09, 2025, 09:00 ET Clinical Trial Shows Pycnogenol® Significantly Relieves Lipedema Symptoms and Improves Quality of Life in Women
physical therapy and lifestyle adjustments, which can help but do not address the underlying condition.Pycnogenol®'s benefits to Lipedema stem from its antioxidant and anti-inflammatory properties, which help strengthen blood vessel walls, improve microcirculation and support lymphatic flow.
More news about: Horphag Research (USA) Inc.
Dec 09, 2025, 07:44 ET Unprecedented results from the Phase 3 MajesTEC-3 study support TECVAYLI® plus DARZALEX FASPRO® as a potential standard of care as early as second line for patients with relapsed/refractory multiple myeloma
and prednisone in newly diagnosed patients who are ineligible for autologous stem cell transplantIn combination with lenalidomide and dexamethasone in newly diagnosed patients who are ineligible for autologous stem cell transplant and in patients with relapsed or refractory multiple myeloma
More news about: Johnson & Johnson
Dec 09, 2025, 03:01 ET NUS scientists create microneedle system to deliver biofertiliser directly into plants, boosting growth with less waste
microbes can migrate within the human body, we hypothesised that by delivering beneficial microbes directly into the plant's tissues, like a leaf or stem, they could travel to the roots and still perform their function, but much more effectively and be less vulnerable to soil conditions," said Assistant
More news about: National University of Singapore
Dec 09, 2025, 00:00 ET Miltenyi Biotec Receives 'Special Recognition Award' for Pioneering Work in Cell & Gene Therapy at BioSpectrum India Excellence Awards 2025
solutions for cellular research, cell therapy, and cell manufacturing. Their more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, cancer, hematology, and graft engineering. In their commitment to the scientific community, they also offer comprehensive
More news about: Miltenyi Biotec
Dec 08, 2025, 18:19 ET The Jackson Laboratory receives an up to $30 million contract award to revolutionize drug safety testing with AI-powered "virtual hearts"
the genetic variability present across patient populations. JAX is a world leader in mouse studies and the use of human stem cells, and with its recent acquisition of the New York Stem Cell Foundation (NYSCF), the team will profile these cellular models at an unprecedented scale using cutting-edge robotic
More news about: The Jackson Laboratory
Dec 08, 2025, 09:05 ET Hip Innovation Technology Updates Orthopedic Community on its Reverse Hip Replacement System
the Reverse HRS consists of a femoral stem, an acetabular cup and a cobalt-chrome ball that articulates within a polyethylene liner. Unlike existing total hip replacement systems, the ball is placed on a trunnion within the acetabular cup instead of the femoral stem, and the polyethylene liner is attached
More news about: Hip Innovation Technology